Innovating Works

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA

Activa
ENDOTARGET: Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic target... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Rheumatic diseases (RDs) affect more than 40% of Europe's population and cause significant disability, pain, reduced lifespan and a very hig...
2022-11-15 - 2026-12-31 | Financiado
NeuProHRI: NeuroProtective role of HRI following cerebral ischemia FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Nowadays, cerebrovascular diseases are devastating conditions representing a large cause of mortality worldwide. It is estimated that 1.1 mi...
2022-08-18 - 2025-05-31 | Financiado
TheranoXome: Engineered Exosomes for Stimuli-responsive Image-guided Drug delivery for Cancer Theranostic applica... UNIVERSIDAD DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 The primary objective of this project is to engineer a non-immunogenic cell-membrane mimicking drug delivery vehicle for remote-controlled p...
2022-08-04 - 2025-08-31 | Financiado
EVOLVE: Isolation and Analysis of Extracellular Vesicles using OptofLuidics for the eValuation of Microsatel... INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Endometrial cancer (EC) is the most common gynaecological cancer, and has an estimated incidence rise of more than 50% worldwide by 2040, ma...
2022-07-19 - 2024-08-31 | Financiado
ColoMARK: Identification and development of novel colorectal cancer biomarkers via state of the art liquid bio... FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 The ColoMARK network integrates 17 teams with multidisciplinary expertise (omics, epidemiology, microbiome, circulating tumour DNA, bioinfor...
2022-07-06 - 2026-10-31 | Financiado
PAINLESS: Pain relief in palliative care of cancer using home based neuromodulation and predictive biomarkers UNIVERSIDAD DE SANTIAGO DE COMPOSTELA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 More than 50% of cancer patients develop pain before death: 80% can be treated with drugs, but 20% show a low response or have serious adver...
2022-05-20 - 2027-05-31 | Financiado
TIMELY: A patient centered early risk prediction prevention and intervention platform to support the conti... UNIVERSITEIT VAN AMSTERDAM tramitó un H2020: H2020-SC1-DTH-2018-2020 Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends o...
2020-12-08 - 2025-03-31 | Financiado
DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE tramitó un H2020: H2020-SC1-BHC-2018-2020 Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado
TRIDOS: Targeted Radiotherapy Internal Dosimetry A platform for individualized patient dosimetry and radiob... FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA tramitó un H2020: H2020-MSCA-IF-2018 In radiation therapy (RT), which is used in more than 50% of cancer treatments, the dose delivered to the tumour/normal tissue determines tu...
2019-04-12 - 2021-10-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.